APA (7th ed.) Citation

Kaboli, P. J., Imani, S., Jomhori, M., & Ling, K. H. (2021). Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy. e-Century Publishing.

Chicago Style (17th ed.) Citation

Kaboli, Parham Jabbarzadeh, Saber Imani, Masume Jomhori, and King Hwa Ling. Chemoresistance in Breast Cancer: PI3K/Akt Pathway Inhibitors Vs the Current Chemotherapy. e-Century Publishing, 2021.

MLA (9th ed.) Citation

Kaboli, Parham Jabbarzadeh, et al. Chemoresistance in Breast Cancer: PI3K/Akt Pathway Inhibitors Vs the Current Chemotherapy. e-Century Publishing, 2021.